EUVIMEDOpdag EUVIMED
MetaanalyseSystematische ÜbersichtOpen access · CC BY-NC 4.0

Systematic review with meta‐analysis: Diagnostic performance of faecal calprotectin in distinguishing inflammatory bowel disease from irritable bowel syndrome in adults

Elton Dajti iD, Leonardo Frazzoni iD, Veronica Iascone, Matteo Secco, Amanda Vestito, Lorenzo Fuccio, Leonardo Henry Eusebi, Pietro Fusaroli, Fernando Rizzello, Carlo Calabrese iD, Paolo Gionchetti, Franco Bazzoli and 1 more

Alimentary Pharmacology & Therapeutics · 2023-12 · 58 (11-12) · 1120-1131

DOI: 10.1111/apt.17754 ↗

At a glance

Metaanalyse in Alimentary Pharmacology & Therapeutics, published online on 2023-10-12. Written by Elton Dajti and 12 co-authors. Institution: Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy. Major MEDLINE topics: Inflammatory Bowel Diseases, Irritable Bowel Syndrome. Cited 46 times so far (Crossref); 40 references. The full text is freely available (open access, CC BY-NC 4.0).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

Symptoms of inflammatory bowel disease (IBD) often overlap with those of irritable bowel syndrome (IBS).

Aim

To evaluate the diagnostic performance of faecal calprotectin in distinguishing patients with IBD from those with IBS Methods We searched MEDLINE, Embase, Scopus, and Cochrane Library databases up to 1 January 2023. Studies were included if they assessed the diagnostic performance of faecal calprotectin in distinguishing IBD from IBS (defined according to the Rome criteria) using colonoscopy with histology or radiology as reference standard in adults. We calculated summary sensitivity and specificity and their 95% confidence intervals (CI) using a random‐effect bivariate model. The risk of bias was assessed using the Quality Assessment of Diagnostic Accuracy Studies II.

Results

We included 17 studies with a total of 1956 patients. The summary sensitivity was 85.8% (95% CI: 78.3–91), and the specificity was 91.7% (95% CI: 84.5–95.7). At a prevalence of IBD of 1%, the negative predictive value was 99.8%, while the positive predictive value was only 9%. Subgroup analyses showed a higher sensitivity in Western than in Eastern countries (88% vs 73%) and at a cut‐off of ≤50 μg/g than at >50 μg/g (87% vs. 79%), with similar estimates of specificity. All studies were at “high” or “unclear” risk of bias.

Conclusions

Faecal calprotectin is a reliable test in distinguishing patients with IBD from those with IBS. Faecal calprotectin seems to have a better sensitivity in Western countries and at a cut‐off of ≤50 μg/g.

Subjects

MeSH terms (MEDLINE)

Inflammatory Bowel DiseasesIrritable Bowel SyndromeAdultHumansBiomarkersFecesLeukocyte L1 Antigen ComplexPredictive Value of TestsSensitivity and Specificity

Author keywords

faecal calprotectininflammatory bowel diseaseirritable bowel syndromesensitivityspecificity

Substances

BiomarkersLeukocyte L1 Antigen Complex

Authors and institutions

  • Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
  • Gastroenterology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, S. Orsola Hospital, Bologna, Italy.
  • Gastro-Esophageal Disease Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, S. Orsola Hospital, Bologna, Italy.
  • Gastroenterology Unit, Hospital of Imola, Imola, Italy.
  • IBD Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, S. Orsola Hospital, Bologna, Italy.

ORCID profiles: Elton Dajti, Leonardo Frazzoni, Carlo Calabrese, Rocco Maurizio Zagari

Cite

APA

Dajti, E., Frazzoni, L., Iascone, V., Secco, M., Vestito, A., Fuccio, L., Eusebi, L. H., Fusaroli, P., Rizzello, F., Calabrese, C., Gionchetti, P., Bazzoli, F., & Zagari, R. M. (2023). Systematic review with meta‐analysis: Diagnostic performance of faecal calprotectin in distinguishing inflammatory bowel disease from irritable bowel syndrome in adults. Alimentary Pharmacology & Therapeutics, 58(11-12), 1120-1131. https://doi.org/10.1111/apt.17754

Vancouver

Dajti E, Frazzoni L, Iascone V, Secco M, Vestito A, Fuccio L, et al. Systematic review with meta‐analysis: Diagnostic performance of faecal calprotectin in distinguishing inflammatory bowel disease from irritable bowel syndrome in adults. Alimentary Pharmacology & Therapeutics. 2023;58(11-12):1120-1131. doi:10.1111/apt.17754

BibTeX
@article{Dajti2023,
  author = {Dajti, Elton and Frazzoni, Leonardo and Iascone, Veronica and Secco, Matteo and Vestito, Amanda and Fuccio, Lorenzo and Eusebi, Leonardo Henry and Fusaroli, Pietro and Rizzello, Fernando and Calabrese, Carlo and Gionchetti, Paolo and Bazzoli, Franco and Zagari, Rocco Maurizio},
  title = {Systematic review with meta‐analysis: Diagnostic performance of faecal calprotectin in distinguishing inflammatory bowel disease from irritable bowel syndrome in adults},
  journal = {Alimentary Pharmacology & Therapeutics},
  year = {2023},
  volume = {58},
  number = {11-12},
  pages = {1120--1131},
  doi = {10.1111/apt.17754}
}
Start for free →